Global Anesthesia Monitoring Devices Market

Anesthesia medication is used to cause a temporary loss of sensation in patients. Anesthesia disposables are the single-use, portable, and easy-to-use devices that prevent the risk of infections in patients. The main products of anesthesia disposables are anesthesia breathing circuits, endotracheal tubes, anesthesia gas masks, and laryngeal mask airway. Laryngeal mask airways (LMA) are supraglottic devices that are used as a temporary method to maintain an open airway during the administration of anesthesia or as an immediate life-saving measure in a patient with a difficult or failed airway. The patient groups are neonatal, adult, and pediatric. The various end-users are hospitals, clinics, home care settings, and other end users. The anesthesia disposables market research report is one of a series of new reports from The Business Research Company that provides anesthesia disposables market statistics, including anesthesia disposables industry global market size, regional shares, competitors with a anesthesia disposables market share, detailed anesthesia disposables market segments, market trends and opportunities, and any further data you may need to thrive in the anesthesia disposables industry. This anesthesia disposables market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global anesthesia disposables market size will grow from $1 billion in 2022 to $1.06 billion in 2023 at a compound annual growth rate (CAGR) of 6.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The anesthesia disposables market size is expected to grow to $1.3 billion in 2027 at a CAGR of 5.2%. The increase in the aging population leads to increased surgeries driving the anesthesia disposable market. Increasing life expectancies paired with age-related comorbidities have resulted in the growth of the elderly population who undergo surgeries. The prevalence of cardiovascular disease, arthritis, thyroid disease, and emphysema is steadily increasing, which is proportionally increasing the number of surgeries coupled with the growing prevalence of diseases. These diseases are found mainly in elderly people, which is increasing the consumption of anesthesia disposables as they are widely used in surgical procedures and are driving the market in the forecast period. Lack of trained anesthesiologists is restraining the market. Anesthetist plays a very vital role in patient's care during and posts any surgery or operation. They acquire the ability to offer a premium level of care to their patients. As with the increase in the number of patients especially for surgery and operations across the globe, the demand for skilled and trained anesthetists also increases. To meet rising patient demand for anesthesia services, countries are facing a critical shortage of skilled and trained anesthetists. For example, the Centre for Workforce Intelligence, a unit of UK NHS staffing agency Health Education England stated that according to their study, the demand for anesthetic services would grow by 25% by 2033, and would require the number of anesthetists to grow by 300 a year. As reported in a study conducted by the American Association of Medical Colleges (AAMC), a shortfall of 33,800 to 72,700 physicians across the specialties is expected by 2030. Thus there is a significant gap in the requirement of trained anesthesiologists across the country which is likely to hinder the growth of the anesthesia disposables market. The demand for cuffed endotracheal tubes (ETTs) in pediatrics is growing as compared to uncuffed ETTs. During pediatric anesthesia, general endotracheal intubation is commonly performed for airway management and positive pressure ventilation. Traditionally, uncuffed endotracheal tubes (ETTs) are recommended for children up to eight years old. But the major disadvantages of the uncuffed ETTs such as an increase in air leakage around the tube, make it difficult to ensure that the child is breathing adequate amounts of oxygen. In addition, the measurement of tidal volume is also compromised. Uncuffed ETTs also allow waste anesthetic gases to escape, contributing significantly to operating room contamination and rendering the anesthetic procedure more expensive. Therefore, the trend is towards increasing the usage of cuffed ETTs for pediatric procedures. According to the American Association of Nurse Anesthetists, facilities should select disposables registered with the U.S. Environmental Protection Agency (EPA) and follow manufacturer recommendations regarding use, exposure time, and disposal. Also, they should discard disposable single-use devices in a biohazardous bag/container (e.g., breathing circuits, airway devices, orogastric tubes) immediately after use. Major players in the anesthesia disposables market are Ambu A/S, Medline Industries Inc., Smiths Medical, Teleflex Inc., Vyaire Medical Inc., Armstrong Medical Ltd., Hamilton Medical AG, Intersurgical Ltd., Medtronic PLC., and Mercury Medical. Asia-Pacific was the largest region in the global anesthesia disposables market in 2022. Western Europe was the second-largest region in the anesthesia disposables market. The regions covered in the global anesthesia disposables market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the anesthesia disposables market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The anesthesia disposables market consists of sales of instruments such as anesthesia circuits, anesthesia masks, sample lines, filters/Heat & Moisture Exchangers (HMEs), breathing bag, endotracheal tubes, and laryngeal masks. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global anesthesia disposables market is segmented - 1) By Product: Anesthesia Breathing Circuits, Endotracheal Tubes, Anesthesia Gas Masks, Laryngeal Mask Airway 2) By End Users: Hospitals, Clinics, Home Care Settings, Other End users 3) By Patient Group: Neonatal, Adult, Pediatric

Veterinary anesthesia equipment refers to a type of device or instrument that is composed of a number of components that work together to support breathing and safely deliver inhalant anesthetic agents into patients' bodies to prevent pain or discomfort during surgical procedures. The main types of veterinary anesthesia equipment market are standalone anesthesia machines, portable anesthesia machines, which are used for small and large animals. The "standalone anesthesia machines" refer to the equipment that provides anesthesia to the animals. These are used in veterinary hospitals, veterinary clinics, emergency service centers, veterinary homecare settings. The veterinary anesthesia equipment research report is one of a series of new reports from The Business Research Company that provides veterinary anesthesia equipment statistics, including veterinary anesthesia equipment industry global market size, regional shares, competitors with veterinary anesthesia equipment share, detailed veterinary anesthesia equipment segments, market trends and opportunities, and any further data you may need to thrive in the veterinary anesthesia equipment industry. This veterinary anesthesia equipment research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global veterinary anesthesia equipment market size will grow from $0.73 billion in 2022 to $0.78 billion in 2023 at a compound annual growth rate (CAGR) of 8.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global veterinary anesthesia equipment market size is expected to grow from $1.03 billion in 2027 at a compound annual growth rate (CAGR) of 7.1%. The rising prevalence of oral diseases in dogs and cats is driving the market for veterinary anesthesia equipment used during oral examinations. Diagnosis and treatment of oral diseases. Dental cleaning requires pet animals to be under general anesthesia as it is difficult to handle animals when they are awake and conscious. According to the American Veterinary Dental College, periodontal disease is the most common clinical condition occurring in adult dogs and cats. Thus, the rising prevalence of oral diseases in pet animals is increasing the demand for veterinary anesthesia equipment driving the market growth. The high prices of veterinary anesthetic equipment are acting as a restraint on the market. It is expensive for small veterinary hospitals and clinics to buy and maintain anesthesia equipment, thereby limiting market penetration. The high price of the equipment can be attributed to the advanced technology used in the equipment. Manufacturers of veterinary anesthesia equipment are introducing products with advanced features to provide a safe and reliable treatment. The new products being introduced offer solutions to problems like power failure, battery failure or exhaustion, and failure of electronic components. Companies such as DRE veterinary and Supera have been investing in introducing anesthetic machines with safety features. Manufacturers of veterinary anesthesia equipment are required to adhere to stringent regulations set by various regulatory bodies. For instance, the US Food and Drug Administration’s (FDA) Center for Veterinary Medicine (CVM) regulates the market for veterinary devices in the USA. The FDA issues guidelines concerning the manufacturing, procuring, packaging, branding, selling, and usage of medical devices. Also, the FDA encourages veterinarians and pet owners to report defects in veterinary medical equipment. Major players in the veterinary anesthesia equipment market are JD medical, Midmark Corporation, Smiths Medical, Mindray Medical, Kent Scientific, Everest Veterinary Technology, Dispomed Ltd., Henry Schein Company, Mediquip, and Patterson Scientific. North America was the largest region in the veterinary anesthesia equipment market in 2022. Asia-Pacific was the second-largest region in the global veterinary anesthesia equipment market. The regions covered in the global veterinary anesthesia equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the veterinary anesthesia equipment market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, and USA. The veterinary anesthesia equipment market consists of sales of high-pressure anesthesia, intermediate pressure anesthesia, and low-pressure anesthesia. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global veterinary anesthesia equipment market is segmented - 1) By Type: Standalone Anaesthesia Machines, Portable Anaesthesia Machines 2) By End User: Veterinary Hospitals, Veterinary Clinics, Emergency Service Centres, Veterinary Homecare Settings 3) By Animal Type: Small, Large

Anesthetics refer to any refer to any substance, including pain, that causes a local or widespread lack of sensation. Anesthesia suppresses reactions to sensory input by acting on the brain or peripheral nervous system. These drugs are used to give a sense of calm to patients through muscle relaxation, which also causes amnesia. The main types of anesthetics are general anesthetics and local anesthetics. A medically induced coma with a lack of defensive reflexes is known as general anesthesia. It is caused by the injection of one or more general anesthetic drugs. The different routes of administration include Inhalation Anaesthesia Drugs, Intravenous Anaesthesia Drugs, and Topical Anaesthesia Drugs and are used in various applications such as General Surgeries, Plastic Surgery, Cosmetic Surgeries, Dental Surgeries, and Other Applications. The anesthetics market research report is one of a series of new reports from The Business Research Company that provides anesthetics market statistics, including anesthetics industry global market size, regional shares, competitors with an anesthetics market share, detailed anesthetics market segments, market trends, and opportunities, and any further data you may need to thrive in the aesthetics industry. This anesthetics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global anesthetics market size will grow from $9.97 billion in 2022 to $10.49 billion in 2023 at a compound annual growth rate (CAGR) of 5.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global anesthetics market size is expected to grow to $12.34 billion in 2027 at a CAGR of 4.1%. The increase in the number of surgeries is one of the major drivers of the anesthetics market due to the applications of anesthetic drugs during surgical procedures. This rise is mainly due to increasing incidents of injuries and accidents that require surgeries. For example, according to WHO's Global status report on road safety, the number of road accidents reached 1.35 million, with approximately 64 deaths for every 100,000 vehicles. Stringent guidelines and regulations imposed by regulatory bodies are one the important restraints for the anesthetics market. These guidelines include conducting clinical trials of newly developed drugs, standards related to patient safety, and monitoring of patients under anesthesia. Complying with these guidelines and getting regulatory approvals consumes a lot of time and negatively impacts the growth of the anesthetics market. For example, the American Society of Anesthesiologists imposes various standards that apply to anesthesia care and monitoring of patients including standards for pre-, basic- and post-anesthesia care and monitoring. Increasing consolidation in the form of acquisitions is an emerging trend in the anesthetics market. This is mainly due to the high level of R&D and intellectual property (IP) investment needed to establish companies that manufacture anesthetic drugs. In this regard, mergers and acquisitions are considered a time and cost-effective methods. Some of the notable acquisitions in recent years include the acquisition ofFDHSAnesthesia LLC by CRH Medical Corporation in 2020, the acquisition of Claris Injectables by Baxter for $625 million, the acquisition of GSK's anesthetics portfolio by Aspen for $238.7 million, and acquisition of Hospira by Pfizer for $17 billion. Major players in the anesthetics market are Baxter, Abbott Laboratories, AstraZeneca, F. Hoffmann-La Roche AG, B. Braun Melsungen AG, AbbVie Inc., Hospira, Aspen, BoehringerIngelheim International GmbH and Eisai Co. Ltd. North America was the largest region in the anesthetics market in 2022. Middle East is expected to be the fastest-growing region in the global anesthetics market during the forecast period. The regions covered in the global anesthetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the anesthetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The anesthetics market consists of sales of isoflurane, desflurane, sevoflurane, and nitrous oxide. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global anesthetics market is segmented - 1) By Type: General Anesthetics, Local Anesthetics 2) By Application: General Surgeries, Plastic Surgery, Cosmetic Surgeries, Dental Surgeries, Other Applications 3) By Route of Administration: Inhalation Anaesthesia Drugs, Intravenous Anaesthesia Drugs, Topical Anaesthesia Drugs 4) By Local Anesthetics: Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Articaine, Benzocaine, Other Local Anesthesia Drugs 5) By General Anesthetics: Propofol, Sevoflurane, Desflurane, Dexmedetomidine, Remifentanil, Midazolam, Other General Anesthesia Drugs

Anesthesia machines are used to deliver anesthetic agents and gases to patients for the purpose of introducing and maintaining anesthesia. The main products in the anesthesia machines are mobile anesthesia machines and standalone anesthesia machines. The anesthesia machine is used to give anesthesia to patients which helps them feel no pain at the time of medical surgeries. The main types are continuous anesthesia machines and intermittent anesthesia machines, and others. The various end-users involved are hospitals, clinics, and ambulatory surgical centres. The anesthesia machines market research report is one of a series of new reports from The Business Research Company that provides anesthesia machines market statistics, including anesthesia machines industry global market size, regional shares, competitors with a anesthesia machines market share, detailed anesthesia machines market segments, market trends and opportunities, and any further data you may need to thrive in the anesthesia machines industry. This anesthesia machines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global anesthesia machines market size will grow from $18.87 billion in 2022 to $20.86 billion in 2023 at a compound annual growth rate (CAGR) of 10.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global anesthesia machines market size is expected to grow to $29.91 billion in 2027 at a CAGR of 9.4%. The increasing number of surgeries is a major driver for the anesthesia machines market. This is because anesthetic machines are one of the important pieces of equipment used for surgeries to ensure that patients do not feel pain during surgeries. With the increasing number of chronic illnesses like cataracts, nervous disorders, muscle repair, oral problems, and abdominal issues that require surgeries, the use of anesthesia machines has also increased. According to an article published by the British Journal of Anaesthesia, an annual average of 7.9 million procedures (inclusive category), 5.1 million procedures (intermediate category), and 1.5 million procedures (restrictive category) were performed in hospitals in the UK. The risk of contamination because of the use of anesthesia machines during surgical procedures is an important restraint for the anesthesia machines market. This is mainly because the chances of bacterial infections are getting higher with an increasing number of surgeries and the use of anesthesia machines. Many anesthesia machines are often colonized by microorganisms. One such example is an anesthesia machine's outer region which contains bacterial species that may be transferred from the machine to the anesthetist and then to the patient, resulting in bacterial contamination and infection. The use of computer-controlled anesthesia machines is an emerging trend in the anesthesia machines market. Computer-controlled anesthesia machines help in reducing the patient's pain during surgical procedures and also provide features such as alarms to notify in case of an emergency or backup required to switch the defected pipeline or cylinder. For example, the Dräger Primus anesthesia workstation provides advanced display and monitoring settings and an automatic checkup option, thereby reducing human time and efforts. Similarly, GE Healthcare’s Aisys CS² station manages the oxygen flow, records the consummation data, and avoids wastage of fresh gas. The Food and Drug Administration (FDA) regulated the anesthesia machines manufacturing market. The anesthesia gas machines fall under the class II category of the FDA medical devices regulation. Most of the Class II devices or machines require approval as per Premarket Notification 510(k) - 21 CFR Part 807 Subpart E. According to this regulation, the manufacturer is not allowed to distribute the devices until it gets an approval letter from the FDA. Some other regulations and laws include the Medical Device Amendments 1976, and the Good Manufacturing Practices, 1978. The Medical Device Amendments outlines procedures for the introduction of new products, labeling for products, and manufacturer registration, and the Good Manufacturing Practices includes laws for quality assurance, distribution, and manufacturing of devices. Hence, regulations such as these would keep a check on manufacturers of anesthesia machines. Major players in the anesthesia machines market are GE Healthcare, Dragerwerk, Smith Medical, Spacelabs Healthcare, COVIDien, Aeonmed, Heyer Medical, Oricare, Dameca A/S, and Getinge Group. North America was the largest region in the anesthesia machines market in 2022. Western Europe was the second largest region in the global anesthesia machines market. The regions covered in the global anesthesia machines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the anesthesia machines market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The anesthesia machines market consists of sales of machines such as intermittent anesthesia machines, continuous anesthesia machines, all-in-one type of anesthesia machines, portable anesthesia machines, high-flow type anesthesia machines, low-flow type anesthesia machines, pediatric anesthesia machines, cycle closed type anesthesia machines and, direct-flow type anesthesia machines. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global anesthesia machines market is segmented - 1) By Product: Mobile Anesthesia Machines, Standalone Anesthesia Machines 2) By End User: Hospital, Clinics, Ambulatory Surgical Centers 3) By Type: Continuous Anaesthesia Machines, Intermittent Anaesthesia Machines, Other Types

Airway management devices are medical techniques and tools for preserving or reestablishing a secure, reliable channel for ventilation and oxygenation. Airway management devices are used to prevent and relieve airway obstruction to ensure the proper exchange of air between the patient’s lungs and atmosphere. The main types of airway management devices are infraglottic airway management devices, supraglottic airway management devices, resuscitators, laryngoscopes, and other devices. The infraglottic airway management devices are used to prevent and relieve airway obstruction to ensure the proper exchange of air between the patient’s lungs and atmosphere. These are used for applications such as anesthesia, emergency medicine, others that are used by hospitals and homecare. The airway management devices market research report is one of a series of new reports from The Business Research Company that provides airway management devices market statistics, including airway management devices industry global market size, regional shares, competitors with a airway management devices market share, detailed airway management devices market segments, market trends and opportunities, and any further data you may need to thrive in the airway management devices industry. This airway management devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global airway management devices market grew from $2.36 billion in 2022 to $2.49 billion in 2023 at a compound annual growth rate (CAGR) of 5.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The airway management devices market is expected to grow from $2.98 billion in 2027 at a CAGR of 4.6%. The increasing prevalence of respiratory diseases is expected to propel the demand for airway management devices market over the forecast period. Airway management devices are used for difficult emergency airway management during medical procedures. According to the American Lung Association, in 2020, 148,512 people died from COPDs in the US making it sixth overall leading cause of death and fifth disease-related cause of death. Lung cancer was the deadliest cancer with 1.76 million deaths annually across the world. Moreover, 10 million people develop tuberculosis and 334 million people suffer from asthma every year. This scenario drives the growth of the airway management devices market. The complications and failures associated with airway management devices limit the growth of airway management devices. According to BioMed Research International Journal, the concerns or complications related to the supraglottic and other airway management devices include compression of vascular structures, regurgitation, aspiration of gastric contents, trauma, and nerve injury. Therefore, higher incidences of complications associated with the airway management devices question the use of devices in the first place and likely harm the market growth. The launch of innovative airway management devices is shaping the airway management devices market. For instance, in December 2021, McMurray Enhanced Airwar (MEA) was named as 2021 EMS world innovation awards winner. The MEA is specially designed to quickly open a patient’s airway facilitating ventilation and oxygenation. Similarly, in June 2020, Docsinnovent Ltd launched an advanced version of V-gel, which is a supraglottic airway device for cats and rabbits. Major players in the airway management devices market are Medtronic, Smiths Medical (A Division of Smiths Group PLC), Teleflex, Ambu, Karl Storz, Flexicare, Intersurgical, Carefusion, Mercury Medical, and Well Lead Medical Co Ltd. North America was the largest region in the airway management devices market in 2022. Western Europe was the second largest region in the global airway management devices market report.The regions covered in the global airway management devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the airway management devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The airway management devices market consists of sales of oropharyngeal airway (OPA), nasopharyngeal airway (NPA), and endotracheal airway (ETA). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global airway management devices market is segmented - 1) By Type: Infraglottic Airway Management Devices, Supraglottic Airway Management Devices, Resuscitators, Laryngoscopes, Other Devices 2) By End Use: Hospital, Homecare 3) By Application: Anesthesia, Emergency Medicine, Other Applications

Anesthesia and respiratory devices are used in the diagnosis and treatment of respiratory diseases. This market includes respiratory devices that are used to provide medication for medical conditions such as asthma, cystic fibrosis, acute cute respiratory distress syndrome, and others. The main types of anesthesia and respiratory devices are respiratory devices and equipment (therapeutic and diagnostic), anesthesia machines, anesthesia disposables, and respiratory disposables. The respiratory disposables are designed to be discarded after excessive breathing resistance, sorbent exhaustion, physical damage, or end-of-service-life renders it unsuitable for use. The type of expenditure is public and private. The products used are instruments/equipment and disposables. The end-users are hospitals and clinics, diagnostic laboratories, and others. The anesthesia and respiratory devices market research report is one of a series of new reports from The Business Research Company that provides anesthesia and respiratory devices market statistics, including anesthesia and respiratory devices industry global market size, regional shares, competitors with a anesthesia and respiratory devices market share, detailed anesthesia and respiratory devices market segments, market trends and opportunities, and any further data you may need to thrive in the anesthesia and respiratory devices industry. This anesthesia and respiratory devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global anesthesia and respiratory devices market grew from $51.73 billion in 2022 to $57.75 billion in 2023 at a compound annual growth rate (CAGR) of 11.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The anesthesia and respiratory devices market is expected to grow to $86.16 billion in 2027 at a CAGR of 10.5%. The preference for wearable and portable medical devices is increasing and companies in the respiratory devices market are developing wearable respiratory devices to improve patient monitoring. Wearable respiratory devices are mainly worn on the torso and are used to calculate the patient’s breathing rate by measuring movements of the chest wall. They are available in various forms such as small dimensional sensors, belts, and band-aid-like devices. These devices are usually connected to speciality smartphone apps that capture and interpret data and store the data in cloud data repositories focusing on main areas of respiratory healthcare including pulse oximetry, pulmonary ventilation, air quality assessment, and activity tracking. Wearable respiratory devices reduce the workload of healthcare providers, improve the efficiencies of diagnostics, reduce costs incurred by patients in regular checkups and improve patients’ comfort. Researchers at the University of California and Khine Labs are investing in major research projects to develop comfortable wearables for patients suffering from respiratory diseases. Major companies in the anesthesia and respiratory devices market include Koninklijke Philips N.V., Resmed, Cardinal Health, Inc., 3M Company, Medtronic Inc., Boston Scientific Corporation, Fisher & Paykel Healthcare Corporation Limited, Olympus Corporation, Teleflex Inc., and Getinge Group. Asia-Pacific was the largest region in the global anesthesia and respiratory devices market in 2022. North America was the second largest region in the global anesthesia and respiratory devices market. Eastern Europe was the smallest region in the global anesthesia and respiratory devices market. The regions covered in the anesthesia and respiratory devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the anesthesia and respiratory devices market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The anesthesia and respiratory devices market consists of sales of instruments such as resuscitators, laryngoscopes, flexible intubation scopes, supraglottic airways, ventilator circuits, HME, and other anesthesia and respiratory instruments that are used for the diagnosis and treatment of respiratory diseases. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global anesthesia and respiratory devices market is segmented - 1) By Type: Respiratory Devices And Equipment (Therapeutic And Diagnostic), Anesthesia Machines, Anesthesia Disposables, Respiratory Disposables 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables

Inhalation anesthesia refers to medications used in operating rooms to induce and maintain general anaesthesia. In addition to other therapeutic effects, it causes drowsiness that ranges from mild to severe, up to and including general anaesthesia. The inhalation anesthesia is used for the induction and maintenance of general anesthesia in the operating room. The main product of inhalation anesthesia includes sevoflurane, desflurane, isoflurane, and nitrous oxide. Isoflurane is a general anesthetic that is inhaled and used to induce and maintain general anesthesia. It relaxes muscles and reduces pain sensitivity by modifying tissue excitability. The applications of inhalation anesthesia include induction and maintenance. The end-users of inhalation anesthesia include hospitals and ambulatory surgical centers. The inhalation anesthesia market research report is one of a series of new reports from The Business Research Company that provides Inhalation anesthesia market statistics, including inhalation anesthesia industry global market size, regional shares, competitors with an inhalation anesthesia market share, detailed inhalation anesthesia market segments, market trends and opportunities, and any further data you may need to thrive in the inhalation anesthesia industry. This inhalation anesthesia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global inhalation anesthesia market size grew from $1.36 billion in 2022 to $1.45 billion in 2023 at a compound annual growth rate (CAGR) of 6.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The inhalation anesthesia market size is expected to grow to $1.9 billion in 2027 at a CAGR of 7.1%. The increasing geriatric population is anticipated to propel the growth of inhaled anesthetic drugs during the forecast period. The increasing geriatric population is boosting the inhalation anesthesia market as they are highly prone to degenerative diseases and chronic illnesses, which eventually leads to a rise in surgeries and therapeutics. Moreover, the increasing geriatric population, which is more susceptible to ailments, such as cardiovascular, neurological, respiratory, and degenerative disorders, is boosting the market growth. It is usually inconvenient to administer anesthesia through an intravenous route to geriatric patients due to punctured blood vessels and issues with patient compliance. For instance, in 2020, according to a United Nations report, the share of the population aged 65 years or over is expected to increase from 9.3% in 2020 to around 16.0% in 2050. Therefore, the increasing geriatric population is expected to boost demand for inhalation anesthesia during the forecast period. Technological advancements are a key trend gaining popularity in the inhalation anesthesia market. Many companies operating in inhalation anesthesia are developing new products or new technologies to meet industry demands and strengthen the market position across the globe. For instance, in April 2020, Hikma Pharmaceuticals plc, a UK-based manufacturer of non-branded generic and in-licensed pharmaceutical products launched Vecuronium Bromide for Injection, 10mg. Vecuronium Bromide for Injection is used as an adjunct to general anesthesia to help with endotracheal intubation and to relax skeletal muscles during surgery or mechanical ventilation. In January 2022, Dechra Pharmaceuticals UK-based specialist veterinary pharmaceuticals and related products business acquired Isoflurane USP Inhalant Anesthetic and Sevoflurane USP Inhalant Anesthetic from Halocarbon Life Sciences for an undisclosed amount. With this acquisition, Isoflurane and Sevoflurane come as an addition to Dechra’s pharmaceutical companion animal portfolio Dechra’s companion animal portfolio, focusing on endocrinology, anesthesia, fluid therapy, dermatology, ophthalmology, pain management, joint health support, and dental care. Halocarbon Life Sciences is a US-based leader in the supply of isoflurane and sevoflurane inhalation anesthetic products for human and veterinary applications. Major players in the inhalation anesthesia market are Abbvie Inc., Baxter International Inc., Fresenius SE & Co. KGaA, Halocarbon Products Corporation, Hikma Pharmaceuticals PLC, Lunan Pharmaceutical Group Co. Ltd., Piramal Enterprises Ltd., Troikaa Pharmaceuticals, Ltd., Jiangsu Hengrui Medicine Co., Ltd., and Sandoz International GmbH. North America was the largest region in the inhalation anesthesia market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inhalation anesthesia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the inhalation anesthesia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The inhalation anesthesia market consists of sales of nitrous oxide, halothane, isoflurane, desflurane, and sevoflurane. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global inhalation anesthesia market is segmented - 1) By Product: Sevoflurane, Desflurane, Isoflurane, Nitrous Oxide 2) By Application: Induction, Maintenance 3) By End User: Hospitals, Ambulatory Surgical Centers

The operating room equipment market consists of sales of operating room equipment and related services. Operating room equipment is used during surgery and includes surgical beds, operating tables, operating table accessories, operating room lights, operating room integration systems and equipment management systems. The global operating room equipment market is expected to grow from $7.9 billion in 2019 to $10.8 billion in 2020 at a compound annual growth rate (CAGR) of 35.8%. The growth is mainly due to the COVID-19 outbreak and the surge in demand for hospitals supplies including personal protective equipment, surgical supplies, sterilization equipment, disinfectants and hospital beds, among others. With the increasing number of cases, hospitals are flooded with COVID-19 positive patients. In order to meet demand and address the supply shortage concerns, most of the hospitals have also suspended the non-urgent medical procedures. The market is then expected to grow at a CAGR of 3.8% from 2021 and reach $11.7 billion in 2023. The operating room equipment market has been geographically segmented into North America, Western Europe, Asia-Pacific, Eastern Europe, South America and Middle East & Africa. The North American market is the largest market for operating room equipment and is expected to continue to be the largest market during the forecast period. The operating room (OR) equipment market is driven globally by the increase in ambulatory surgical centers (ASCs) across the world. All ASCs require an operating room (OR) to undertake the surgeries; therefore the growing number of ASCs all over the world is a key factor facilitating growth of the market for OR equipment. The high cost associated with the operating room equipment will restrain the operating room equipment market growth. Hospital costs are important to understanding value-based care, and are even more critical when analyzing cost-saving interventions during surgery. The costs associated with the operating room equipment depends on the country, the surgical procedure and the equipment used for the surgical procedure. In a 2011 study, it was observed that on an average, hospital stays in the US that involve an OR procedure have been reported to be 2.5 times more costly than stays that do not involve an OR procedure. The hybrid operating room is a new trend being observed in the global operating room market. A hybrid operating room is an alternative to conventional operating room equipped with advanced medical imaging systems and devices which support high quality interventional imaging and minimally invasive surgeries. It has complex environment in which numerous surgeons, nurses, anesthesiologists, and technicians work together. Hybrid operating rooms in healthcare facilities has increased globally. Since they offer a sterile operating room environment, surgeons can perform surgeries with ease. The ability of these operating rooms to reduce the total healthcare expenditure, enhance patient safety, and minimize the time taken to perform surgeries will lead to its increased popularity in the fields of neurosurgery, cardiology, and orthopedics. In December 2018, Medtronic`s subsidiary, Restorative Therapies Group, acquired Mazor Robotics (Mazor), a pioneer in the field of robotic guidance systems. The acquisition of Mazor strengthens the company`s position as a global leader in enabling technologies for spine surgery. The company offers a fully-integrated procedural solution for surgical planning, execution and confirmation by combining the company`s spine implants, navigation, and intra-operative imaging technology with Mazor`s robotic-assisted surgery systems. Total consideration for the transaction, net of cash acquired, was $1.6 billion, consisting of $1.3 billion of cash and $246 million of a previously-held equity investment in Mazor.